Profil
James Fortune worked as a Principal at Johnson & Johnson.
He then served as the Chief Operating Officer at Access Closure, Inc. from 2008 to 2010.
After that, he worked as the Chief Operating Officer at Confluent Surgical, Inc., Augmenix, Inc., Intrinsic Therapeutics, Inc., and Ostial Corp.
In 2017 to 2018, he was the Chief Accounting & Operating Officer at Ocular Therapeutix, Inc. Mr. Fortune received his undergraduate degree from Rensselaer Polytechnic Institute.
Ehemalige bekannte Positionen von James Fortune
| Unternehmen | Position | Ende |
|---|---|---|
Augmenix, Inc.
Augmenix, Inc. Medical SpecialtiesHealth Technology Develops hydrogel technology to improve outcomes in radiation oncology and surgery | Geschäftsführer | 01.04.2014 |
Access Closure, Inc.
Access Closure, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes the vascular closure devices in the United States | Geschäftsführer | 01.01.2010 |
| OCULAR THERAPEUTIX, INC. | Finanzdirektor/CFO | 06.04.2017 |
Ostial Corp.
Ostial Corp. Medical/Nursing ServicesHealth Services Develops catheter-based delivery system combined with a bare metal stent | Geschäftsführer | - |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
Ausbildung von James Fortune
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Access Closure, Inc.
Access Closure, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes the vascular closure devices in the United States | Health Technology |
Confluent Surgical, Inc.
Confluent Surgical, Inc. Medical SpecialtiesHealth Technology Designs and develops medical devices | Health Technology |
Ocular Therapeutix, Inc.
Ocular Therapeutix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for retinal diseases & conditions of the eye | Health Technology |
Augmenix, Inc.
Augmenix, Inc. Medical SpecialtiesHealth Technology Develops hydrogel technology to improve outcomes in radiation oncology and surgery | Health Technology |
Rensselaer Polytechnic Institute
Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intrinsic Therapeutics, Inc.
Intrinsic Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops device-based therapies for soft-tissue injuries of the spine | Health Technology |
Ostial Corp.
Ostial Corp. Medical/Nursing ServicesHealth Services Develops catheter-based delivery system combined with a bare metal stent | Health Services |
















